TD Cowen lowered shares of Celsius (NASDAQ:CELH - Free Report) from a buy rating to a hold rating in a research report report published on Wednesday, Marketbeat reports. TD Cowen currently has $29.00 price target on the stock, down from their prior price target of $40.00.
A number of other equities research analysts have also recently commented on the company. Morgan Stanley reissued an "equal weight" rating and set a $42.00 price target on shares of Celsius in a report on Thursday, December 26th. Truist Financial lifted their target price on Celsius from $30.00 to $35.00 and gave the company a "hold" rating in a research note on Wednesday, October 16th. Stifel Nicolaus dropped their price target on Celsius from $51.00 to $45.00 and set a "buy" rating for the company in a research note on Thursday, November 7th. JPMorgan Chase & Co. began coverage on shares of Celsius in a research report on Thursday, December 12th. They set an "overweight" rating and a $37.00 price objective on the stock. Finally, Needham & Company LLC restated a "buy" rating and set a $38.00 target price on shares of Celsius in a research report on Monday, January 6th. One research analyst has rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $48.78.
Get Our Latest Stock Analysis on CELH
Celsius Price Performance
Shares of CELH stock traded down $1.46 during trading hours on Wednesday, reaching $25.35. 12,558,782 shares of the company traded hands, compared to its average volume of 6,939,203. The firm has a 50-day moving average price of $28.08 and a 200 day moving average price of $34.26. The company has a market cap of $5.96 billion, a P/E ratio of 35.21, a P/E/G ratio of 2.99 and a beta of 1.79. Celsius has a 12-month low of $25.23 and a 12-month high of $99.62.
Insiders Place Their Bets
In other news, major shareholder William H. Milmoe sold 65,000 shares of the business's stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $31.15, for a total value of $2,024,750.00. Following the completion of the sale, the insider now owns 261,245 shares in the company, valued at approximately $8,137,781.75. The trade was a 19.92 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 2.20% of the company's stock.
Hedge Funds Weigh In On Celsius
Hedge funds and other institutional investors have recently modified their holdings of the business. Dimensional Fund Advisors LP raised its stake in Celsius by 86.9% in the second quarter. Dimensional Fund Advisors LP now owns 990,135 shares of the company's stock valued at $56,531,000 after buying an additional 460,227 shares during the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in Celsius by 353.1% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 648 shares of the company's stock worth $37,000 after purchasing an additional 505 shares in the last quarter. Xponance Inc. grew its position in Celsius by 7.8% during the 2nd quarter. Xponance Inc. now owns 40,607 shares of the company's stock worth $2,318,000 after purchasing an additional 2,928 shares during the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its stake in Celsius by 63.4% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 29,026 shares of the company's stock valued at $1,657,000 after purchasing an additional 11,258 shares in the last quarter. Finally, Toronto Dominion Bank raised its holdings in shares of Celsius by 22.8% in the second quarter. Toronto Dominion Bank now owns 17,893 shares of the company's stock worth $1,022,000 after buying an additional 3,326 shares during the last quarter. 60.95% of the stock is currently owned by institutional investors.
About Celsius
(
Get Free Report)
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Read More
Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.